All In Biotech

Drug Trial Radar · NCT07163845

Assessment of Chikungunya Virus Seroprevalence Before VLA1553 Vaccination in the Municipalities Selected for Participation in the VLA1553 Pilot Vaccination Strategy in Brazil

Last checked: Nov 19, 2026Latest source record: Feb 11, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

5,354

Actual

Start

Sep 22, 2025

Primary completion

Jul 31, 2026

Study completion Dec 31, 2026

Sponsor

Lead sponsor
Valneva Austria GmbHIndustry
Sponsor type
Industry
Collaborators
Butantan Foundation; Coalition for Epidemic Preparedness Innovations
First posted
Sep 9, 2025

More drug trials from this sponsor

Design

Study type
Observational
FDA-regulated drug
No
Who can join
All sexes, from 2 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This is a cross-sectional serosurvey using household cluster sampling conducted before the VLA1553 pilot vaccination strategy will be implemented in about 10 municipalities in Brazil.

Conditions

  • Chikungunya Virus Infection

Interventions

  • Live-attenuated CHIKV vaccine VLA1553Biological

    Non-interventional study: VLA1553 is used in the pilot vaccination strategy which is carried out after this observational study.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To prospectively evaluate the association between vaccination uptake and previous CHIKV exposure (pre-existing immunity to CHIKV infection) after implementing a pilot vaccination in the age-group approved per label.Time frame: on Day 1

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • Universidade Federal Do Ceará

    Fortaleza, Ceará, Brazil

  • Universidade Federal de Minas Gerais, CT Terapias Avançadas e Inovadoras

    Belo Horizonte, Minas Gerais, Brazil

  • Fundação Faculdade Regional De Medicina De São José Do Rio Preto

    São Pedro, São Paulo, Brazil

  • Centro de Pesquisas Clínicas Universidade Federal Sergipe, Hospital e Maternidade São João de Deus

    Laranjeiras, Sergipe, Brazil

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.